Preliminary evaluation of the usefulness of Tc-99m (V) DMSA in pancreatic neuroendocrine tumors

Clinical Nuclear Medicine

Volumn 21, Issue 2, 1996, Pages 122-124

  Banci, Maria ^a,c   Bianchi, Pier Luigi ^b   Gianni, Walter ^b   Romani, Anna Maria ^b   De Vincentis, Giuseppe ^a   Ierardi, Maria ^a   Scopinaro, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SUCCIMER TC 99M;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROENDOCRINE TUMOR; PANCREAS SCINTISCANNING; PANCREAS TUMOR; WHOLE BODY SCINTISCANNING;

FEMALE; HUMANS; INSULINOMA; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; ORGANOTECHNETIUM COMPOUNDS; PANCREATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; SUCCIMER; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID; VIPOMA;

EID: 0030023995     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199602000-00009     Document Type: Article

References (21)

1. Ohta H, Endo K, Fujita T, et al: Imaging of soft tissue tumor with Tc (V)-99m dimercaptosuccinic acid: A new tumor-seeking agent. Clin Nucl Med 9:568, 1984.
2. Ohta H, Yamamoto K, Endo K, et al: A new imaging agent in medullary carcinoma of the thyroid. J Nucl Med 25:323, 1984.
3. Clarke SE, Lazarus CR, Mistry R, et al: The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid. Br J Radiol 60:1089, 1987.
4. Mojiminiyi OA, Udelsman R, Soper NDW, et al: Pentavalent Tc-99m DMSA scintigraphy: Prospective evaluation of its role in the management of patients with medullary carcinoma of the thyroid. Clin Nucl Med 16:259, 1991.
5. Bigsby RJ, Lepp EK, Litwin DEM, et al: Technetium 99m pentavalent dimercaptosuccinic acid and thallium 201 in detecting recurrent medullary carcinoma of the thyroid. Can J Surg 35:388, 1992.
6. Watkinson J, Clarke SE, Shaheen OH: An evaluation of the uptake of technetium-99m (V) dimercaptosuccinic acid in patients with squamous carcinoma of the head and neck. Clin Otolaryngol 12:405, 1987.
7. Watkinson J, Lazarus CR, Mistry R, et al: Technetium-99m (V) dimercaptosuccinic acid uptake in patients with head and neck squamous carcinoma: Experience in imaging. J Nucl Med 30:174, 1989.
8. Galasco CSB: Mechanism of uptake of bone imaging isotopes by skeletal metastases. Clin Nucl Med 5:565, 1980.
9. Jeghers O, Puttemans N, Urbain D, et al: Technetium-99m DMSA uptake by metastatic carcinoma of the prostate. J Nucl Med 27:1223, 1986.
10. Kashyap R, Babbar A, Sahai I, et al: Tc-99m (V) DMSA imaging: A new approach to studying metastases from breast carcinoma. Clin Nucl Med 17:119, 1992.
11. Bal CS, Raina V, Padhy AK, et al: Pentavalent technetium-99m dimercaptosuccinic acid scintigraphy is useful in diagnosis and localization of neuroblastoma. (letter) Postgrad Med J 68:769, 1992.
12. Kobayashi H, Sakahara H, Itoh T, et al: Technetium-99m (V) dimercaptosuccinic acid uptake in intra-abdominal massive deposit of amyloid protein. J Nucl Med 34:815, 1993.
13. Baylin SB, Mendelsohn G: Ectopic (inappropriate) hormone production by tumors: Mechanisms involved and the biological and clinical implications. Endocr Rev 1:45, 1980.
14. Stevens RE, Moore GE: Inadequacy of APUD concept in explaining production of peptide hormones by tumours. Lancet 1:118, 1983.
15. Bloom SR, Polak JM: Glucagonomas, Vipomas and somatostatinomas. Clin Endocrinol Metab 9:285, 1980.
16. Lamberts SWJ, Hofland LJ, van Koetsveld PM, et al: Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: Consequences with regard to diagnosis, localization and therapy. J Clin Endocrinol Metab 71:566, 1990.
17. Joseph K, Stapp J, Reinecke J, et al: Rezeptor-szintigraphie bei endokrinen gastroenteropankreatischen tumoren. Dtsch Med Wochenschr 117:1025, 1992.
18. 3-octreotide: The Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:716, 1993.
19. 99mTc (V) dimercaptosuccinic acid as a tumour-seeking agent. IAEA Proceedings Series, Vienna, 1985, pp 201-209.
20. Watkinson JC, Allen SJ, Laws DE, et al: The pharmacokinetics and biodistribution of technetium-99m (V) dimercaptosuccinic acid in an animal tumor model. J Nucl Med 32:1235, 1991.
21. Kao C-H, Wang S-J, Wey S-P, et al: Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs. Eur J Nucl Med 19:890, 1992.